Published in World Neurosurg on November 07, 2011
Technical note regarding immediate titanium mesh cranioplasty for postcraniotomy infections. World Neurosurg (2013) 0.75
Long-term results following reconstruction of craniofacial defects with titanium micro-mesh systems. J Craniomaxillofac Surg (2001) 1.62
Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg (2003) 1.47
Titanium cages in the surgical treatment of severe vertebral osteomyelitis. Eur Spine J (2003) 1.45
Analyses of the factors influencing bone graft infection after delayed cranioplasty. Acta Neurochir (Wien) (2006) 1.41
Single-stage treatment of pyogenic spinal infection with titanium mesh cages. J Spinal Disord Tech (2006) 1.40
Anterior surgery with insertion of titanium mesh cage and posterior instrumented fusion performed sequentially on the same day under one anesthesia for septic spondylitis of thoracolumbar spine: is the use of titanium mesh cages safe? Spine (Phila Pa 1976) (2006) 1.31
Long-term results following titanium cranioplasty of large skull defects. Neurosurg Focus (2009) 1.28
A prospective study of computer-aided design and manufacture of titanium plate for cranioplasty and its clinical outcome. Br J Neurosurg (1999) 1.21
Individual prefabricated titanium implants in reconstructive craniofacial surgery: clinical and technical aspects of the first 22 cases. Plast Reconstr Surg (1998) 1.07
Use of calcium-based bone cements in the repair of large, full-thickness cranial defects: a caution. Plast Reconstr Surg (2007) 1.06
Salvage of infected craniotomy bone flaps with the wash-in, wash-out indwelling antibiotic irrigation system. Technical note and case series of 12 patients. J Neurosurg (2006) 1.06
Biomechanical testing of alloplastic PMMA cranioplasty materials. J Craniofac Surg (2005) 1.03
The use of allograft or autograft and expandable titanium cages for the treatment of vertebral osteomyelitis. Neurosurgery (2009) 0.97
Management of postneurosurgical bone flap loss caused by infection. Plast Reconstr Surg (2008) 0.95
Successful treatment of spondylodiscitis using titanium cages: a 3-year follow-up of 22 consecutive patients. Acta Orthop (2008) 0.93
Titanium in reconstructive surgery of the skull and face. Br J Plast Surg (1990) 0.93
Biomechanical analysis of hydroxyapatite cement cranioplasty. J Craniofac Surg (2004) 0.93
Preservation of bone flaps in patients with postcraniotomy infections. J Neurosurg (2003) 0.90
Preservation of bone flap after craniotomy infection. Neurocirugia (Astur) (2009) 0.84
[Osteomyelitis due to Salmonellae in sickle cell anemia]. Minerva Pediatr (1976) 0.81
[Postoperative infection following craniotomy in adults]. Med Mal Infect (2004) 0.80
[Management of craniofacial bone defects with individually prefabricated titanium implants. Follow-up and evaluation of 78 patients with 78 titanium implants 1994-1998]. Mund Kiefer Gesichtschir (2001) 0.80
Delayed extrusion of hydroxyapatite cement after transpetrosal reconstruction. Neurosurgery (2009) 0.80
Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (2002) 15.36
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res (2003) 8.06
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res (2005) 3.63
Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron (2012) 2.84
Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol (2010) 2.67
Epidemiology of intracranial meningioma. Neurosurgery (2005) 2.60
A 24-year-old woman with intractable seizures: review of surgery for epilepsy. JAMA (2008) 2.55
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol (2004) 2.24
Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys (2009) 2.07
Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer (2005) 1.97
Neurosurgery certification in member societies of the WFNS: global overview. World Neurosurg (2011) 1.87
Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther (2003) 1.65
History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer (2002) 1.62
Intracranial dural metastases. Cancer (2009) 1.59
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. J Clin Oncol (2009) 1.58
Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol (2006) 1.57
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res (2006) 1.54
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol (2011) 1.53
Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res (2009) 1.52
DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol (2009) 1.51
Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer (2005) 1.50
Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer (2006) 1.49
Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res (2006) 1.44
Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology (2006) 1.42
Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery. Neuroimage (2006) 1.41
In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res (2004) 1.40
Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells (2009) 1.40
Neurosurgery certification in member societies of the WFNS: Europe. World Neurosurg (2011) 1.39
Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res (2009) 1.38
Capturing intraoperative deformations: research experience at Brigham and Women's Hospital. Med Image Anal (2004) 1.35
Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res (2007) 1.33
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev (2003) 1.28
SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer (2010) 1.26
Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol (2008) 1.26
Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci (2008) 1.24
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer (2007) 1.20
Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma. Cancer Res (2007) 1.17
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev (2007) 1.17
N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle (2007) 1.17
Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. J Neurooncol (2007) 1.15
Image-guided neurosurgery at Brigham and Women's Hospital. IEEE Eng Med Biol Mag (2006) 1.14
Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol (2008) 1.13
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro Oncol (2011) 1.09
PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res (2005) 1.08
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer (2012) 1.08
High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors. Int J Oncol (2010) 1.07
Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J (2003) 1.05
Matrix solution fixation: histology-compatible tissue preparation for MALDI mass spectrometry imaging. Anal Chem (2007) 1.05
Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res (2010) 1.04
Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol (2012) 1.04
Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res (2009) 1.03
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. J Natl Cancer Inst (2007) 1.03
Neurosurgery certification in member societies of the World Federation of Neurosurgical Societies: Asia. World Neurosurg (2011) 1.03
Techniques and complications of external lumbar drainage for normal pressure hydrocephalus. Neurosurgery (2008) 1.02
Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res (2008) 1.02
The Harvard Neurosurgical Service at the Children's Hospital Boston and Brigham & Women's Hospital, 1912-2007. Neurosurgery (2008) 1.00
Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy. J Magn Reson (2008) 0.99
Continuous daily sunitinib for recurrent glioblastoma. J Neurooncol (2012) 0.99
Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol (2011) 0.99
Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol (2012) 0.98
Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann Neurol (2012) 0.98
Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med (2007) 0.97
Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev (2003) 0.97
A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery (2007) 0.97
A phase I/II trial of vandetanib for patients with recurrent malignant glioma. Neuro Oncol (2012) 0.97
Sociodemographic indicators and risk of brain tumours. Int J Epidemiol (2003) 0.97
Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer (2011) 0.96
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma. Ann Neurol (2011) 0.94
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol (2006) 0.93
Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro Oncol (2012) 0.92
Origins of intraoperative MRI. Neurosurg Clin N Am (2009) 0.91
Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal Chem (2010) 0.91
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008) 0.90
Occupation and risk of meningioma and acoustic neuroma in the United States. Am J Ind Med (2004) 0.90
The development of ring-shaped contrast enhancement in a case of cerebellar dysembryoplastic neuroepithelial tumor: case report. Neurosurgery (2008) 0.90
Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest (2002) 0.89
Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma. Int J Radiat Oncol Biol Phys (2012) 0.89
An update on therapy of primary central nervous system lymphoma. Hematology Am Soc Hematol Educ Program (2006) 0.89
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia (2012) 0.89
In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. FASEB J (2007) 0.88
Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol (2007) 0.88
Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol (2008) 0.87
Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer (2008) 0.87
Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Clin Cancer Res (2009) 0.86
A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin (2004) 0.85
Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect (2005) 0.85
Compensation of geometric distortion effects on intraoperative magnetic resonance imaging for enhanced visualization in image-guided neurosurgery. Neurosurgery (2008) 0.85
Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels. PLoS One (2013) 0.85
Statistical validation of brain tumor shape approximation via spherical harmonics for image-guided neurosurgery. Acad Radiol (2005) 0.85
Occupational exposure to magnetic fields and the risk of brain tumors. Neuro Oncol (2009) 0.84
Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Int J Alzheimers Dis (2011) 0.84
Handedness and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev (2003) 0.84
Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam. J Clin Psychopharmacol (2003) 0.84
Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells. Cancer Res (2008) 0.83
Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. Am J Epidemiol (2006) 0.82
A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction pain. J Oral Maxillofac Surg (2007) 0.82
Origins of intraoperative MRI. Magn Reson Imaging Clin N Am (2010) 0.82